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Glycogen metabolism shapes ventromedial hypothalamic nucleus (VMN) control of glucose homeostasis. Brain glycogen mass 
undergoes compensatory expansion post‑recovery from insulin‑induced hypoglycemia (IIH). Current research utilized combinatory 
high‑resolution microdissection/high‑sensitivity Western blotting to investigate whether IIH causes residual adjustments in glycogen 
metabolism within the metabolic‑sensory ventrolateral VMN (VMNvl). Micropunch‑dissected tissue was collected from rostral, middle, 
and caudal levels of the VMNvl in each sex for analysis of glycogen synthase (GS) and glycogen phosphorylase (GP)‑muscle type (GPmm; 
norepinephrine‑sensitive) and GP‑brain type (GPbb; glucoprivic‑sensitive) isoform expression during and after IIH. Hypoglycemic 
suppression of VMNvl GS levels in males disappeared or continued after reestablishment of euglycemia, according to sampled segment. 
Yet, reductions in female VMNvl GS persisted after IIH. Males exhibited reductions in GPmm content in select rostro‑caudal VMNvl 
segments, but this protein declined in each segment post‑hypoglycemia. Females, rather, showed augmented or diminished GPmm 
levels during IIH, but no residual effects of IIH on this protein. In each sex, region‑specific up‑ or down‑regulation of VMNvl GPbb profiles 
during glucose decrements were undetected post‑recovery from IIH. Results provide novel proof of estradiol‑dependent sex‑dimorphic 
patterns of VMNvl GP variant expression at specific rostro‑caudal levels of this critical gluco‑regulatory structure. Sex differences in 
persistence of IIH‑associated GS and GPmm patterns of expression after restoration of euglycemia infer that VMNvl recovery from this 
metabolic stress may involve dissimilar glycogen accumulation in male versus female.
Key words: insulin‑induced hypoglycemia, letrozole; micropunch dissection, ventrolateral ventromedial hypothalamic nucleus, glycogen 
phosphorylase‑muscle type
INTRODUCTION
The brain consumes a disproportionate fraction of 
total body energy to sustain vital high energy‑demand 
nerve cell activities. Iatrogenic insulin (INS)‑induced 
hypoglycemia (IIH) is an unremitting complication of 
obligatory glycemic management practiced by type I 
diabetes mellitus patients (Cryer, 2013; 2014). Hypo‑
glycemic neuro‑glucopenia poses a significant risk of 
neurological impairment (Auer and Siesjö, 1988; 1993; 
Auer, 2004). Glucoprivation elicits neural‑driven count‑
er‑regulatory autonomic, neuroendocrine, and behav‑
ioral outflow that increases circulating glucose levels. 
Cellular energy stability is continuously monitored in 
the ventromedial hypothalamic nucleus (VMN) and 
other select brain loci by dedicated metabolic‑senso‑
ry neurons that adjust synaptic transmission in re‑
sponse to excessive or diminished substrate fuel supply 
(Oomura et al., 1969; Ashford et al., 1990; Adachi et al., 
1995, 1997; Silver and Erecińska, 1998). This dynamic 
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readout, together with hormonal indicators of periph‑
eral energy reserves, provides critical input for VMN 
regulation of glucose homeostasis. The ventrolateral 
VMN (VMNvl), one of a unique set of sex‑dimorphic 
structures in the brain (Simerly, 2002), contains meta‑
bolic‑sensory neurons (Cotero and Routh, 2009; Santia‑
go et al., 2016) that participate in gluco‑regulation (He 
et al., 2020). 
Brain astrocytes store the complex carbohydrate 
glycogen as an energy reserve (Stobart and Anderson, 
2013). Glycogen metabolism is controlled by the en‑
zymes glycogen synthase (GS) and glycogen phosphor‑
ylase (GP), which respectively catalyze glycogen assem‑
bly or breakdown. Norepinephrine‑sensitive GP‑muscle 
(GPmm) and glucoprivic sensitive GP‑brain (GPbb) type 
isoforms (Nadeau et al., 2018) confer stimulus‑specific 
regulation of brain glycogen. Pharmacological inhibi‑
tion of VMN glycogen disassembly up‑regulates marker 
protein expression for neurotransmission of signal en‑
ergy deficiency, which infers that local metabolic‑sen‑
sory neurons gauge glycogen turnover and associated 
substrate fuel liberation (Alhamami et al., 2017; Briski et 
al., 2021). The prospect that hypoglycemia may produce 
sex‑specific adjustments in glycogen metabolism with‑
in the sex‑dimorphic VMNvl has not been addressed. 
Current studies utilized a combinatory high‑resolu‑
tion microdissection/high‑sensitivity Western blot 
approach to investigate the premise that basal and/or 
hypoglycemic patterns of VMNvl glycogen metabolic 
enzyme expression differ between sexes. The VMNvl 
exhibits high estrogen receptor (ER) content compared 
to dorsomedial and central divisions (Yang and Shah, 
2014). Thus, a corollary objective of this research was 
to determine if estradiol mediates sex‑contingent GS 
and/or GP protein responses to hypoglycemia in one or 
both sexes. Here, target proteins were analyzed after 
VMNvl micropunch dissection from subcutaneous (sc) 
letrozole (Lz)‑ or vehicle‑injected male and sc estradi‑
ol‑ or oil‑implanted ovariectomized (OVX) female rats 
after INS or vehicle injection for analysis. 
Transitory exposure to physiological conditions 
leading to energy imbalance, e.g., hypoxia, gluco‑
privation, and sleep deprivation, purportedly causes 
adaptive post‑exposure augmentation of whole‑brain 
glycogen content (Brucklacher et al., 2002; Kong et al., 
2002; Choi et al., 2003). There has been speculation that 
post‑hypoglycemic expansion of the glycogen reserve 
may adversely attenuate counter‑regulation (Herzog et 
al., 2008; Duarte et al., 2017; Öz et al., 2017). This view 
has remained controversial, in part, due to a lack of 
methods of requisite neuroanatomical resolution for 
analysis of glycogen metabolism within sites where 
metabolic sensory neurons reside. The current project 
afforded the novel opportunity to examine whether 
regulatory effects of IIH on VMNvl glycogen metabolic 
enzyme protein expression coincide with plasma glu‑
cose decrements and/or are demonstrable following 
reestablishment of euglycemia in one or both sexes. 
METHODS
Adult male and female Sprague Dawley were housed 
in groups by sex (2‑3 per cage), under a 14 h light/10 h 
dark cycle (lights on at 05: 00 h). Animals were allowed 
unrestricted access to standard laboratory rat chow 
and water, and were acclimated to daily handling. 
Five days before the study, female rats were bilaterally 
OVX under ketamine/xylazine (0.1 mL/100 g bw; 90 mg 
ketamine: 10 mg xylazine/mL; Henry Schein Inc., Mel‑
ville, NY) anesthesia. After surgery, rats were inject‑
ed subcutaneously (sc) with ketoprofen (1 mg/kg bw) 
and intramuscularly with enrofloxacin (10 mg/0.1 mL), 
treated by topical application of 0.25% bupivacaine to 
closed incisions, then transferred to individual cages. 
On day 1 of the experiment, randomly‑assigned female 
rats were anesthetized with isoflurane for sc implan‑
tation of a estradiol (30 ug 17β estradiol‑3‑benzoate/
mL safflower oil)‑ or oil‑filled silastic capsule (i.d. 0.062 
in./o.d. 0.125 in.; 10 mm/100 g bw). This validated hor‑
mone replacement paradigm was used to standardize 
plasma estradiol levels at metestrus‑like levels to avoid 
between estrous cycle‑associated variations in endog‑
enous steroid concentrations in ovary‑intact animals 
(Briski et al., 2001). On days 1‑5, testes‑intact male rats 
were randomly injected sc with the aromatase inhibitor 
letrozole (Lz; 1 mg/kg bw) or the vehicle 0.9% saline 
(SAL) containing 5.0% Tween‑30 and 5.0% ethanol, as 
described (Bhatnagar et al., 1993). At 09: 00 h on day 
6, animals of each sex were injected with neutral pro‑
tamine Hagedorn insulin (INS; 10.0 U/kg bw) or ster‑
ile diluent (V), then sacrificed by microwave fixation 
(1.45 sec; In Vivo Microwave Fixation System, 5kW; Sto‑
elting Co., Wood Dale, IL) at the following time points 
(Fig. 1A): V‑injected controls: time zero (n=4 V‑ and 
n=4 Lz‑pretreated males; n=4 estradiol‑ and n=4 oil‑im‑
planted females); INS‑injected animals: +1.0 h (n=4 V‑ 
and n=4 Lz‑pretreated males; n=4 estradiol‑ and n=4 
oil‑implanted females), +3.5 h (n=4 V‑ and n=4 Lz‑pre‑
treated males; n=4 estradiol‑ and n=4 oil‑implanted fe‑
males), or +7.0 h (n=4 V‑ and n=4 Lz‑pretreated males; 
n=4 estradiol‑ and n=4 oil‑implanted females). Individ‑
ual dissected brains were snap‑frozen in liquid nitro‑
gen‑cooled isopentane and stored at ‑80°C. Plasma was 
kept at −20°C for glucose measurement.
All surgical and experimental protocols were con‑
ducted in accordance with the National Institutes of 
Health Guide for the Care and Use of Laboratory Ani‑
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mals, 8th Edition, under approval by the ULM Institu‑
tional Animal Care and Use Committee.
VMN tissue micropunch dissection  
and Western blot analysis
Each brain was cut into consecutive coronal 
10 μm‑thick frozen sections over the length of VMN. 
For each animal, bilateral micropunches of VMNvl tis‑
sue were taken using a calibrated 0.5 mm hollow punch 
tool (prod. no. 57401; Stoelting Co., Kiel, WI; Fig. 1B) 
from sections cut at rostral (‑1.8 to ‑2.3 mm), middle 
(‑2.3 to ‑2.8), and caudal (‑2.8 to ‑3.3 mm) levels of the 
VMNvl, and combined within each segment in lysis buf‑
fer (2.0% sodium dodecyl sulfate, 0.05M dithiothreitol, 
10.0% glycerol, 1.0 mM EDTA) for Western blot analy‑
sis. Regional micro‑dissection of VMNvl tissue was per‑
formed here as recent studies show that INS‑induced 
hypoglycemia effects on whole‑VMN glycogen content 
vary along the longitudinal axis of the VMN (Ibrahim 
et al., 2020b). Accuracy of use of micropunch method‑
ology for collection of distinctive hypothalamic loci of 
interest, including the VMN, as indicated by marker 
protein expression, has been validated (Mandal et al., 
2017; 2018). In each treatment group, tissue lysate al‑
iquots from individual subjects were pooled from ros‑
tral middle, or caudal VMNvl segments to create for 
each target protein, at minimum, triplicate sample 
pools per level. Pooled tissue samples were separated 
in Bio‑Rad TGX 10% stain‑free gels (Bio‑Rad, Hercules, 
CA); after electrophoresis, gels were UV light‑activated 
(1 min) in a Bio‑Rad ChemiDoc TM Touch Imaging Sys‑
tem (Ibrahim et al., 2019) to quantify total protein con‑
tent in each lane. After protein transblotting, 0.45‑μm 
PVDF‑Plus membranes (prod. no. 121639; Data Support 
Co., Panorama City, CA) were blocked with Tris‑buffer 
saline containing 0.1% Tween‑20 and 2.0% bovine se‑
rum albumin, then incubated between 36‑42 h (4°C) 
with primary rabbit polyclonal antisera raised against 
GS (1:2,000; prod. no. 3893S; Cell Signaling Technology, 
Danvers, MA), GPmm (1:2,000; prod. No. NBP2‑16689; 
Fig. 1. Experimental design and ventromedial hypothalamic nucleus‑ventrolateral part (VMNvl) micropunch dissection. (A) groups of male were pretreated 
on study days 1‑5 by serial once‑per‑day subcutaneous (sc) injection of vehicle (V) or letrozole (Lz), while ovariectomized (OVX) female rats were implanted 
with a sc silastic capsule containing estradiol or the vehicle safflower oil over the same time interval. Groups of male V‑ or Lz‑pretreated rats and groups 
of female estradiol‑ or oil‑implanted OVX animals were injected sc at time zero (to) with vehicle (V; sterile diluent; sacrificed at to) or insulin (INS; 10.0 U 
neutral protamine Hagedorn insulin/kg bw; sacrificed at 1.0, 3.5, or 7.0 h after injection). For each sex, each final treatment group consisted of n=4 rats. 
(B) the rectangle the rectangle in the Panel A brain map (‑2.85 mm posterior to bregma) depicts the VMN within the mediobasal hypothalamus, and is 
enlarged (Panel B) to illustrate the location of VMN in that region. The blue circle denotes positioning of a 0.50 mm diameter circular micropunch tool over 
the VMNvl for selective harvesting of this substructure. ARH: arcuate hypothalamic n.; DMHa,p: anterior, posterior dorsomedial hypothalamic n.; fx: fornix; 
LHA: lateral hypothalamic area; ME: median eminence; PVi: intermediate periventricular hypothalamic n.; VMHc,dm,vl: central, dorsomedial, ventrolateral 
ventromedial hypothalamic n.; TU: tuberal n.; V3: third ventricle.
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Novus Biologicals, Littleton, CO), or GPbb (1:2,000; 
prod. no. NBP1‑32799; Novus Biol.). Membranes were 
sequentially exposed to goat anti‑rabbit horseradish 
peroxidase‑labeled secondary antibodies (1:5,000; prod. 
no. NEF812001EA; PerkinElmer, Waltham, MA) and Su‑
perSignal West Femto maximum sensitivity chemilu‑
minescence substrate (prod. no. 34096; ThermoFish‑
erScientific, Waltham, MA). Automated membrane 
buffer washes and blocking and antibody incubations 
were performed in a Freedom Rocker™ Blotbot. Protein 
band optical density (OD) measures were normalized to 
total in‑lane protein using Image Lab™ 6.0.0 software 
(Bio‑Rad). Precision plus protein molecular weight dual 
color standards (prod. no. 161‑0374, Bio‑Rad) were in‑
cluded in each Western blot analysis.
Statistics
Mean normalized VMNvl segmental protein OD and 
plasma glucose measures were evaluated within each 
sex by two‑way analysis of variance and Student‑New‑
man‑Keuls post‑hoc test. Differences of p<0.05 were 
considered significant. In each figure., statistical dif‑
ferences between specific pairs of treatment groups 
are denoted as follows: *p<0.05; **p<0.01; ***p<0.001; 
****p<0.0001.
RESULTS
Current research investigated the premise that 
insulin‑induced hypoglycemia effects on VMNvl gly‑
cogen metabolic enzyme expression occur by estradi‑
ol‑dependent mechanisms in one or both sexes, and 
that altered expression of one or both GP isoforms may 
persist in distinctive rostro‑caudal segments of the 
VMNvl after recovery from hypoglycemia. Here, com‑
binatory high‑resolution microdissection/high‑sensi‑
tivity Western blotting was used to measure GP, GPmm, 
and GPbb protein expression profiles in rostral, middle, 
and caudal regions of the VMNvl in male rats pretreat‑
ed with Lz or V, as well as OVX female rats implanted 
with estradiol or oil.
Data presented in Table I show that INS‑injected male 
and female rats exhibited reductions in plasma glucose 
concentrations compared to V‑injected controls at both 
+1 and +3.5 h post‑treatment. In each sex, restoration of 
glucose profiles to the normal range occurred between 
+3.5 and +7 h. INS effects on circulating glucose levels 
were not different between groups of males that were 
pretreated with Lz versus V, or between groups of estra‑
diol‑ versus oil‑implanted OVX female rats.
Rostral, middle, and caudal VMNvl tissue was col‑
lected from Lz‑ or V‑pretreated male (Figs 2A, 2C, 2E) 
and estradiol‑ or oil‑implanted OVX female (Figs 2B, 
2D, 2F) rats after INS (patterned bars) or V (solid bars) 
injection for Western blot for GS protein expression. 
Lz administration to euglycemic males decreased 
baseline GS expression in the rostral (Fig. 2A) and 
caudal (Fig. 2E) VMNvl. INS injection of V‑pretreated 
males (right‑side; white bars) caused significant re‑
duction of rostral (+3.5 h), middle (+7 h; Fig. 2C), and 
caudal (+1, 3.5, 7 h) VMNvl GS content. Lz pretreat‑
ment (left‑side; gray bars) resulted in either augmen‑
tation (rostral VMNvl; +1, 3.5, 7 h) or no change (mid‑
dle and caudal VMNvl) in this protein profile after 
INS treatment. In non‑INS‑injected female controls, 
VMNvl GS expression was significantly higher in es‑
tradiol‑ versus oil‑implanted animals in both rostral 
(Fig. 2B) and caudal (Fig. 2F) segments of the VMNvl. 
In the presence of estradiol (left‑side; gray bars), INS 
decreased GS content in the rostral (+3.5, 7 h) and cau‑
dal (+1, 3.5, 7 h) VMNvl. However, this protein profile 
was diminished by INS treatment only in the middle 
VMNvl in OVX rats (Fig. 2D; right‑side; white bars). 
Results show that in each sex, estradiol‑dependent 
mechanisms suppress GS protein expression in specif‑
Table I. Effects of insulin (INS) injection on plasma glucose levels in vehicle‑ versus letrozole (Lz)‑pretreated male and ovariectomized (OVX), estradiol‑ versus 
oil‑implanted female rats.
Post‑INS Injection Time Point
Treatment Group  
Sex/Pretreatment Time Zero +1 h +3.5 h +7 h
Male/Vehicle 130.3 ± 2.2 74.6 ± 4.4* 62.2 ± 6.8* 122.2 ± 6.7
Male/Lz 189.6 ± 7.6 85.4 ± 2.6* 82.0 ± 3.7* 130.3 ± 13.4
Female/OVX‑Estradiol 124.6 ± 7.1 55.3 ± 3.3* 67.0 ± 4.8* 103.5 ± 5.9
Female/OVX‑Oil 116.5 ± 5.8 46.9 ± 3.5* 62.8 ± 4.6* 125.0 ± 8.2
* p<0.05 compared to Time Zero.
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Fig.  2. Effects of sc INS injection on ventrolateral ventromedial hypothalamic nucleus (VMNvl) glycogen synthase (GS) protein expression in V‑ or 
Lz‑pretreated male and estradiol‑ or oil‑Implanted OVX female rats. VMNvl tissue was bilaterally micropunch‑dissected over predetermined rostro‑caudal 
levels from groups of male and female rats after sc vehicle (V; sterile diluent) or INS (10.0 U neutral protamine Hagedorn insulin/kg bw) injection. Data 
depict mean normalized rostral ((A) male, (B) female), middle ((C) male,  (D) female), and caudal ((E) male, (F) female) VMNvl GS protein optical density (OD) 
measures + S.E.M. for groups of male (left‑hand column) and female (right‑hand column) rats. Groups of male rats (n=4/group) were pretreated by serial 
daily sc injection of V‑ (gray bars) or Lz (white bars) prior to sacrifice after V injection (solid bars) or at 1.0 (diagonal‑striped bars), 3.5 (cross‑hatched bars), 
or 7.0 (stippled bars) h after INS injection. Groups of OVX estradiol‑ (gray bars) or oil (white bars)‑implanted female rats (n=4/group) were sacrificed at 
identical time points after V or INS treatment. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001.
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Fig. 3. VMNvl rostrocaudal segment‑specific patterns of glycogen phosphorylase‑muscle type (GPmm) Expression after V‑ versus INS‑injection to male and 
female rats. Data show mean normalized rostral ((A) male, (B) female), middle ((C) male,  (D) female), and caudal ((E) male, (F) female) VMNvl GPmm O.D. 
measures + S.E.M. for groups of male (left‑hand column) and female (right‑hand column) rats. Groups of male rats (n=4/group) were pretreated by serial 
daily sc injection of V‑ (gray bars) or Lz (white bars) prior to sacrifice after V injection (solid bars) or at 1.0 (diagonal‑striped bars), 3.5 (cross‑hatched bars), 
or 7.0 (stippled bars) hrs after INS injection. Groups of OVX estradiol‑ (gray bars) or oil (white bars)‑implanted female rats (n=4/group) were sacrificed at 
identical time points after V or INS treatment. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001.
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ic rostro‑caudal levels of the VMNvl during hypogly‑
cemia. Compared to euglycemic controls, post‑hypo‑
glycemic patterns of GS expression were diminished 
throughout the male VMNvl as well as in the female 
rostral and caudal VMNvl. 
Fig. 3 depicts effects of INS injection on VMNvl 
GPmm protein expression during and after diminu‑
tion of plasma glucose concentrations. Euglycemic 
male rats exhibited a reduction in VMNvl GPmm pro‑
files in the rostral (Fig. 3A) and caudal (Fig. 3F) VMN‑
vl following Lz administration. In this sex, INS sig‑
nificantly inhibited rostral and caudal VMNvl GPmm 
content both during and after glucose decrements. 
While INS‑injected males showed no change in mid‑
dle VMNvl GPmm levels during hypoglycemia, this 
protein profile was subsequently reduced after rees‑
tablishment of plasma glucose levels to the normal 
range. Lz pretreatment prevented hypoglycemia‑as‑
sociated decline in rostral VMNvl GPmm content, but 
did not prevent diminution of this protein profile at 
+7 h. Post‑hypoglycemic decrements in the male rat 
middle VMNvl GPmm were also refractory to Lz. Yet, 
Lz‑pretreated males had modified patterns of GPmm 
expression in the caudal VMNvl during and after hy‑
poglycemia. Data illustrated in Figs 3B, 3D, and 3F re‑
veal divergent INS effects on VMNvl GPmm levels in 
estradiol‑implanted OVX female rats, as this protein 
was up‑regulated in the rostral segment (+3.5 h), but 
down‑regulated at middle and caudal levels (+1 h). 
In contrast, INS injection did not influence VMNvl 
GPmm profiles in oil‑implanted OVX female rats. In 
the presence of estradiol, post‑hypoglycemic GPmm 
expression patterns over the length of the VMNvl 
were equivalent to those in non‑INS‑injected controls. 
Outcomes document uniform versus bi‑directional 
effects of hypoglycemia on VMNvl GPmm content in 
male versus female, respectively, and identify varia‑
tion of post‑hypoglycemic VMNvl GPmm profiles be‑
tween sexes.
Effects of INS injection on male versus female 
VMNvl GPbb protein content are presented in Fig. 4. 
Euglycemic males injected with Lz exhibited signifi‑
cant augmentation of caudal (Fig. 4E), but not rostral 
(Fig. 4A) or middle (Fig. 4C) VMNvl GPbb expression 
compared to V controls. INS injection of male rats re‑
sulted in either stimulation (rostral and middle VMN‑
vl) or suppression (caudal VMNvl) of GPbb content 
by 1 h post‑treatment. These region‑based responses 
were abolished by Lz. In males sacrificed at 7 h after 
INS injection, GPbb profiles in all VMNvl segments did 
not differ from controls. Baseline GPbb levels were sig‑
nificantly lower in rostral (Fig. 4B) and middle (Fig. 4D) 
VMNvl segments of estradiol‑ versus oil‑implanted 
rats. In response to insulin, estradiol‑, but not oil‑im‑
planted female rats exhibited up‑ or down‑regulated 
GPbb expression in rostral (+1 and +3.5 h) and middle 
(+1 h) VMNvl regions, respectively. INS had primarily 
no impact on post‑hypoglycemic VMNvl GPbb content 
in estradiol‑ or oil‑implanted animals. Data indicate 
that region‑specific up‑ or down‑regulation of VMN‑
vl GPbb expression coinciding with diminished plasma 
glucose concentrations is discontinued after recovery 
from hypoglycemia.
DISCUSSION
Glycogen metabolism affects whole‑VMN glu‑
co‑regulatory transmitter signaling (Alhamami et al., 
2017; Briski et al., 2021). Sex‑dimorphic VMNvl sen‑
sitivity to estradiol, due to developmental hormonal 
imprinting, manifests as sex‑specific control of sev‑
eral behavioral and physiological functions. VMNvl 
metabolic‑sensory neurons influence blood glucose 
levels (He et al., 2020). Here, VMNvl tissue was micro‑
punch‑dissected in segmental fashion to investigate 
whether estradiol‑dependent mechanisms mediate 
sex‑specific patterns of glycogen metabolic enzyme 
protein expression in distinctive locations over the 
longitudinal axis of this structure during and/or after 
hypoglycemia. Outcomes document estradiol‑depen‑
dent VMNvl region‑specific GS inhibition during glu‑
cose decrements, a response that persisted post‑hypo‑
glycemia in some (male) or all (female) of those seg‑
ments. INS‑associated diminution of GPmm profiles 
occurred in hypoglycemic animals of each sex, and 
also in recovered male, but not female rats. VMNvl 
GPbb profiles were up‑ or down‑regulated according 
to rostro‑caudal segment during, but not after plasma 
glucose decline. Results infer that during hypoglyce‑
mia, AMP‑driven glycogen breakdown is prioritized 
relative to norepinephrine input in discrete regions 
of the VMNvl. Hypoglycemia may likely impose lin‑
gering inhibitory effects on VMNvl glycogen synthe‑
sis in each sex and on noradrenergic stimulation of 
glycogen breakdown in this structure in males. Fur‑
ther effort is warranted to characterize the molecu‑
lar mechanisms that underlie common versus unique 
patterns of VMNvl glycogen enzyme expression in the 
two sexes, and to determine how glucoprivic‑ versus 
neurotransmitter‑mediated glycogen disassembly 
may affect gluco‑regulatory function over the length 
of the VMNvl.
In each sex, gonad‑derived estradiol is a positive 
stimulus for rostral and caudal VMNvl GS expression 
during euglycemia, but is involved in hypoglycemic 
inhibition of that protein in those same locations. 
These findings likely infer that hypoglycemia sup‑
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Fig. 4. Effects of INS Injection on VMNvl expression of glycogen phosphorylase‑brain type (GPbb) in V‑ or Lz‑pretreated male and estradiol‑ or oil‑implanted 
OVX female rats. Data show mean normalized rostral ((A) male, (B) female), middle ((C) male, (D) female), and caudal ((E) male, (F) female) VMNvl GPbb O.D. 
measures + S.E.M. for groups of male (left‑hand column) and female (right‑hand column) rats. In each sex, bar colors differentiate pretreatments before 
sc V or INS injection; animals were sacrificed after V injection (solid bars) or at 1.0 (diagonal‑striped bars), 3.5 (cross‑hatched bars), or 7.0 (stippled bars) hrs 
after INS injection. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001.
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presses glycogen synthesis at selective levels along the 
longitudinal axis of the VMNvl. There remains a need 
to clarify whether this switch in direction of estradiol 
control of rostral and caudal VMNvl GS may result, 
in part, from dissimilar astrocyte ER expression due 
to differences in glucose uptake during normo‑ ver‑
sus hypoglycemia. Regional differences in VMNvl GS 
reactivity to hypoglycemia may be contingent, some‑
what, upon relative numbers of one or more distinc‑
tive nuclear or membrane ER receptor variants. There 
is also the possibility that control of astrocyte sensi‑
tivity to estradiol input by other regulatory signals 
may vary between rostro‑caudal segments. It is no‑
table that in each sex, the onset of hypoglycemia‑as‑
sociated suppression of GS protein diverged between 
rostral (+3.5 h) versus caudal (+1 h) VMNvl. A sizable 
fraction of glucose acquired by astrocytes from blood 
is diverted to the glycogen shunt, which involves glu‑
cose monomer incorporation into this polymer, then 
release prior to entry into the glycolytic pathway. At‑
tenuation of glycogen assembly during hypoglycemia 
is an effective strategy for energy conservation as 
ATP expenditure is required for glycogen assembly. It 
is thus possible that latency between onset of hypo‑
glycemia and diminution of glycogen synthesis may 
be governed, to some extent, by local nerve cell en‑
ergy requirements. Persistent down‑regulation of GS 
profiles in the male and female caudal VMNvl follow‑
ing recovery from hypoglycemia may similarly reflect 
continuance of heightened neuronal energy demands 
in that segment. Further research is required to ex‑
amine how estradiol signaling may integrate with pu‑
tative cues on neuronal metabolic stability to control 
GS expression and glycogen formation.
Current data document sex‑specific hypoglycemic 
regulation of stimulus‑specific glycogen disassembly 
in the VMNvl. The norepinephrine‑sensitive GP vari‑
ant GPmm was inhibited by INS in different segments 
in each sex, as this protein was decreased at rostral 
and caudal levels in males, but in middle and caudal 
segments in the female. Females also showed coinci‑
dent augmentation of rostral VMN GPmm content. 
Diminution or augmentation of GPmm expression 
likely results in decreased or elevated norepineph‑
rine‑stimulated glycogen disassembly, respectively. 
This premise remains speculative as tools for assess‑
ment of hypoglycemic effects on phosphorylation, 
e.g. activation of this GP isoform are currently un‑
available. Outcomes also show that, in each sex, hy‑
poglycemia simultaneously augmented or inhibited 
glucoprivic‑sensitive GPbb expression in select VMN‑
vl segments. These results infer that AMP‑driven gly‑
cogen breakdown may be correspondingly enhanced 
or reduced in those locations during this metabolic 
stress. Confirmation of this premise will require re‑
gion‑specific analysis of phosphorylation state of 
GPbb protein expressed during hypoglycemia. The 
data summary provided in Table II suggests that in 
hypoglycemic male rats, select VMNvl regional gly‑
cogen stores may be protected from noradrenergic 
disassembly, and at the same time undergo enhanced 
(rostral segment) or attenuated (caudal segment) 
AMP‑mediated mobilization. Thus, in the former site, 
glycogen disassembly may be selectively driven by 
energy deficiency, whereas glycogen mass may be 
preserved in the latter region despite neuro‑glucope‑
nia. In contrast, the female VMNvl is evidently char‑
acterized by regional enhancement (rostral segment) 
or diminution (middle segment) of glycogen sensitiv‑
ity to both noradrenergic and glucoprivic breakdown. 
The possibility that hypoglycemic up‑ or down‑reg‑
ulation of VMNvl GPbb expression, by segment, may 
reflect, to some extent, elevated or decreased energy 
demands needs of local neurons will require further 
investigation. There is ample justification for addi‑
tional effort to verify effects of GPbb‑mediated ac‑
celeration of glucose liberation on metabolic‑sensory 
function. Importantly, outcomes addressed in Table II 
emphasize estradiol involvement in sex‑specific pat‑
terns of GP variant expression during hypoglycemia. 
Table II. Summary of effects of insulin (INS)‑induced hypoglycemia on glycogen synthase (GS) and phosphorylase (GP) isoform protein expression across 
rostro‑caudal segments of male and female rat ventrolateral ventromedial hypothalamic nucleus (VMNvl); role of estradiol.
Male VMNvl Femalea VMNvl
Rostral Middle Caudal Rostral Middle Caudal
GS ↓ +3.5 h ↓ +7 h ↓ +1,3.5,7 h ↓ +3.5,7 h N.C.b +1,3.5,7 h
GPmmc ↓ +1,3.5,7 h ↓ +7 h ↓ +1,3.5,7 h ↑ +3.5 h ↓ +1 h +1 h
GPbbd ↑ +1 h ↑ +1 h ↓ +1 h ↑ +1,3.5 h ↓ +1 h N.C.
a ovariectomized; implanted with estradiol [30 ug/mL; 10 mm/100g bw] – filled silastic capsule sc; b no change; c glycogen phosphorylase‑muscle type; norepinephrine‑sensitive; 
d glycogen phosphorylase‑brain type; AMP‑ sensitive; +    h: underlined time points indicate when response to INS was prevented by sc letrozole administration (males) or 
oil‑filled capsule implanted (females).
Bheemanapally et al. Acta Neurobiol Exp 2021, 81
A possible explanation for these divergent GP re‑
sponses between sexes may involve, in part, dissim‑
ilar of ER expression profiles (Ibrahim et al., 2020). 
Current studies provide novel evidence for resid‑
ual effects of hypoglycemia on VMNvl GPmm, but 
not GPbb variant expression. Notably, post‑hypogly‑
cemic GPmm down‑regulation occurred in male, but 
not female rats; the mechanisms that this sex differ‑
ence remain unclear. Persistent reductions in this 
protein would likely attenuate glycogen breakdown 
in the absence of neuro‑glucopenia. Down‑regulated 
GPmm, coincident with normal (rostral VMNvl) or di‑
minished (middle and caudal VMNvl) patterns of GS 
expression at +7 h after INS injection, plausibly facil‑
itates glycogen enhancement in the former site, yet 
may stabilize glycogen mass in other regions through 
attenuation of glycogen shunt activity. Implications 
of putative post‑hypoglycemia glycogen expansion in 
the male rostral VMNvl on metabolic transmitter sig‑
naling require additional consideration. Female rats 
exhibited suppression of rostral and caudal VMNvl GS 
expression after recovery from hypoglycemia, along‑
side reestablishment of GPmm and GPbb profiles to 
control levels. Post‑hypoglycemia glycogen synthesis 
and glycogen shunt activity are thus likely impeded 
in those areas. As both GP isoforms were up‑regulat‑
ed in the female rat rostral VMNvl during hypogly‑
cemia, glycogen depletion in that segment occurred 
may not be reversed within the post‑hypoglycemia 
interval evaluated here. Functional ramifications of 
possible sex‑dimorphic adaptations in rostral VMNvl 
glycogen accumulation (increased in male, decreased 
in female) after recovery from hypoglycemia warrant 
further attention.
In summary, current research offers unique evi‑
dence for estradiol‑dependent sex‑dimorphic VMN‑
vl glycogen metabolic enzyme protein expression 
during and after exposure to hypoglycemia. Results 
emphasize, for each sex, rostro‑caudal region‑specif‑
ic control of glycogen synthesis and stimulus‑specific 
glycogen mobilization. Further research is needed to 
investigate potential relationships between local ad‑
justments in glycogen metabolism and nerve cell en‑
ergy stability during and after hypoglycemia.
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